Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma.
Pharmaceuticals (Basel)
; 16(7)2023 Jul 12.
Article
in En
| MEDLINE
| ID: mdl-37513907